StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
67
This month
1
This year
7
Publishing Date
2024 - 03 - 06
1
2024 - 02 - 29
3
2024 - 02 - 22
1
2024 - 01 - 17
1
2023 - 11 - 20
1
2023 - 10 - 26
1
2023 - 09 - 26
1
2023 - 09 - 05
2
2023 - 08 - 09
1
2023 - 08 - 07
1
2023 - 07 - 24
1
2023 - 03 - 28
1
2023 - 03 - 06
1
2023 - 03 - 02
1
2023 - 02 - 27
1
2023 - 02 - 02
1
2023 - 01 - 10
1
2022 - 11 - 21
1
2022 - 11 - 08
1
2022 - 11 - 03
1
2022 - 09 - 12
1
2022 - 09 - 10
1
2022 - 09 - 06
1
2022 - 08 - 29
1
2022 - 08 - 04
1
2022 - 07 - 05
1
2022 - 05 - 17
1
2022 - 04 - 08
2
2022 - 03 - 22
2
2022 - 03 - 01
1
2022 - 02 - 24
1
2022 - 01 - 20
1
2022 - 01 - 18
1
2022 - 01 - 11
1
2022 - 01 - 10
1
2021 - 12 - 10
1
2021 - 12 - 08
1
2021 - 12 - 03
1
2021 - 11 - 09
1
2021 - 09 - 08
1
2021 - 09 - 07
1
2021 - 09 - 01
1
2021 - 08 - 25
1
2021 - 07 - 12
1
2021 - 07 - 06
1
2021 - 06 - 28
1
2021 - 06 - 10
1
2021 - 06 - 08
1
2021 - 05 - 20
1
2021 - 04 - 12
1
2021 - 04 - 10
2
2021 - 04 - 08
1
2021 - 03 - 11
1
2021 - 03 - 10
1
2021 - 03 - 03
1
2021 - 02 - 24
1
2021 - 02 - 16
1
2021 - 02 - 11
1
2021 - 01 - 15
1
2020 - 12 - 21
1
Sector
Health services
67
Health technology
8
Tags
Biomarkers
1
Biotech
2
Biotech-beach
13
Biotechnology
5
Business
4
Cancer
16
Care
1
Cell
1
Ces
1
Clinical-trials-phase-ii
5
Collaboration
1
Colorectal cancer
5
Commercialization
1
Conference
14
Crdf-004
1
Ev
1
Events
11
Financial
1
First
1
Gastrointestinal
2
Grant
2
Granted
1
Group
1
Growth
1
Health
2
Iot
1
Ipo
1
Life science
1
Lung
1
Medical
1
Meeting
2
Money
1
N/a
25
Nasdaq
1
Ongoing
2
Onvansertib
10
Ovarian cancer
1
Pancreas
2
Pancreatic
3
People
5
Phase 1
2
Phase 1b
2
Phase 2
4
Phase 2b
3
Pons
1
Positive
1
Preclinical
2
Presentation
3
Program
2
Prostate cancer
1
Publication
1
Report
3
Research
2
Results
8
Study
2
Test
2
Treatment
2
Trial
8
Update
7
Year
3
Entities
Abbott laboratories
81
Agilent technologies, inc.
36
Amazon.com, inc.
35
Amedisys inc
69
American shared hospital services
73
Apollo medical holdings, inc.
51
Aptinyx inc.
60
Aware, inc.
57
Becton, dickinson and company
52
Bio-rad laboratories, inc.
43
Biocept, inc.
101
Biodesix, inc.
78
Brookdale senior living inc.
47
Burning rock biotech limited
66
Cardiff oncology, inc.
67
Centene corporation
306
Cigna corporation
124
Davita inc.
95
Empower clinics inc.
45
Encompass health corporation
88
Exagen inc.
73
Fresenius medical care ag & co. kgaa
60
Fulgent genetics, inc.
82
Guardant health, inc.
117
Guardion health sciences, inc.
35
Icon plc
53
Illumina, inc.
67
Invitae corporation
144
Iqvia holdings, inc.
119
Johnson & johnson
38
Koninklijke philips n.v.
34
Laboratory corporation of america holdings
283
Lhc group
99
Medtronic plc
39
Morgan stanley
44
Natera, inc.
206
National healthcare corporation
62
National research corporation
96
Neogenomics, inc.
127
Oncosec medical incorporated
37
Optinose, inc.
93
Option care health, inc.
58
Premier, inc.
82
Protalix biotherapeutics, inc.
65
Psychemedics corporation
35
Qiagen n.v.
35
Quest diagnostics incorporated
202
Radnet, inc.
95
Sanara medtech inc.
48
Smiledirectclub, inc.
58
Surgery partners, inc.
50
Syneos health, inc.
141
Teladoc health, inc.
109
The ensign group, inc.
56
The joint corp.
53
The pennant group, inc.
47
Thermo fisher scientific inc
105
U.s. physical therapy, inc.
34
Universal health services, inc.
92
Viemed healthcare, inc.
37
Symbols
ANIP
1
CARA
1
CRDF
67
CRIS
1
JNJ
1
LCTX
1
LLY
4
TLIS
1
Exchanges
Amex
1
Nasdaq
67
Nyse
5
Crawled Date
2024 - 03 - 06
1
2024 - 02 - 29
3
2024 - 02 - 22
1
2024 - 01 - 17
1
2023 - 11 - 20
1
2023 - 10 - 26
1
2023 - 09 - 26
1
2023 - 09 - 05
2
2023 - 08 - 09
1
2023 - 08 - 07
1
2023 - 07 - 24
1
2023 - 03 - 28
1
2023 - 03 - 06
1
2023 - 03 - 02
1
2023 - 02 - 27
1
2023 - 02 - 02
1
2023 - 01 - 10
1
2022 - 11 - 21
1
2022 - 11 - 08
1
2022 - 11 - 03
1
2022 - 09 - 12
1
2022 - 09 - 10
1
2022 - 09 - 06
1
2022 - 08 - 29
1
2022 - 08 - 04
1
2022 - 07 - 05
1
2022 - 05 - 17
1
2022 - 04 - 08
2
2022 - 03 - 22
2
2022 - 03 - 01
1
2022 - 02 - 25
1
2022 - 01 - 20
1
2022 - 01 - 19
1
2022 - 01 - 11
1
2022 - 01 - 10
1
2021 - 12 - 10
1
2021 - 12 - 08
1
2021 - 12 - 03
1
2021 - 11 - 09
1
2021 - 09 - 08
1
2021 - 09 - 07
1
2021 - 09 - 01
1
2021 - 08 - 25
1
2021 - 07 - 12
1
2021 - 07 - 06
1
2021 - 06 - 28
1
2021 - 06 - 10
1
2021 - 06 - 08
1
2021 - 05 - 20
1
2021 - 04 - 12
1
2021 - 04 - 10
2
2021 - 04 - 08
1
2021 - 03 - 11
1
2021 - 03 - 10
1
2021 - 03 - 03
1
2021 - 02 - 24
1
2021 - 02 - 16
1
2021 - 02 - 11
1
2021 - 01 - 15
1
2020 - 12 - 21
1
Crawled Time
00:00
1
01:00
1
11:00
1
12:00
1
12:15
1
12:20
1
13:00
4
13:15
1
13:20
3
13:30
2
14:00
8
14:20
1
14:30
2
14:32
1
15:00
3
15:15
1
15:30
1
16:00
3
16:20
2
17:00
1
18:00
3
19:00
3
20:00
7
21:00
7
22:00
4
22:04
1
22:07
1
23:00
2
Source
www.biospace.com
42
www.globenewswire.com
7
www.prnewswire.com
18
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health services
entities :
Cardiff oncology, inc.
save search
Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
Published:
2024-04-08
(Crawled : 20:00)
- globenewswire.com
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
-25.85%
|
O:
0.85%
H:
5.73%
C:
-4.55%
ongoing
preclinical
meeting
study
Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024
Published:
2024-03-06
(Crawled : 21:00)
- globenewswire.com
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
12.08%
|
O:
1.54%
H:
4.3%
C:
-11.14%
meeting
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
Published:
2024-02-29
(Crawled : 21:00)
- globenewswire.com
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
147.03%
|
O:
13.31%
H:
53.5%
C:
45.5%
business
year
update
results
Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004)
Published:
2024-02-29
(Crawled : 21:00)
- globenewswire.com
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
147.03%
|
O:
13.31%
H:
53.5%
C:
45.5%
crdf-004
first
cancer
trial
Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC
Published:
2024-02-29
(Crawled : 21:00)
- globenewswire.com
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
147.03%
|
O:
13.31%
H:
53.5%
C:
45.5%
update
trial
Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update
Published:
2024-02-22
(Crawled : 13:00)
- globenewswire.com
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
159.52%
|
O:
1.19%
H:
1.76%
C:
-0.59%
report
business
year
update
results
Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer Research
Published:
2024-01-17
(Crawled : 15:30)
- prnewswire.com
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
167.48%
|
O:
-2.45%
H:
2.52%
C:
-7.55%
cancer
publication
research
study
Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference
Published:
2023-11-20
(Crawled : 21:00)
- prnewswire.com
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
275.86%
|
O:
0.0%
H:
1.72%
C:
-0.86%
conference
Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update
Published:
2023-10-26
(Crawled : 20:00)
- prnewswire.com
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
323.3%
|
O:
0.63%
H:
5.11%
C:
1.3%
report
business
update
financial
results
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
Published:
2023-09-26
(Crawled : 20:00)
- prnewswire.com
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
169.14%
|
O:
17.9%
H:
4.97%
C:
-16.23%
lung
positive
onvansertib
cancer
pancreatic
cell
Cardiff Oncology to Present at Upcoming Investor Conferences - September 5, 2023
Published:
2023-09-05
(Crawled : 14:30)
- biospace.com/
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
135.68%
|
O:
0.54%
H:
1.08%
C:
-2.69%
Cardiff Oncology to Present at Upcoming Investor Conferences in September
Published:
2023-09-05
(Crawled : 12:00)
- prnewswire.com
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
135.68%
|
O:
0.54%
H:
1.08%
C:
-2.69%
Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update
Published:
2023-08-09
(Crawled : 20:00)
- prnewswire.com
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
128.27%
|
O:
9.95%
H:
4.29%
C:
-1.43%
business
update
results
Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship
Published:
2023-08-07
(Crawled : 20:00)
- prnewswire.com
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
177.71%
|
O:
6.37%
H:
67.07%
C:
30.54%
cancer
program
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published:
2023-07-24
(Crawled : 21:00)
- prnewswire.com
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
192.62%
|
O:
-0.67%
H:
2.03%
C:
-2.7%
nasdaq
grant
Cardiff Oncology Announces First Patient Dosed in ONSEMBLE Phase 2 Randomized Trial of Onvansertib in Patients with Metastatic Colorectal Cancer
Published:
2023-03-28
(Crawled : 14:00)
- biospace.com/
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
198.63%
|
O:
1.37%
H:
4.72%
C:
2.7%
onvansertib
cancer
trial
phase 2
Cardiff Oncology Formally Introduces Scientific Advisory Board
Published:
2023-03-06
(Crawled : 14:00)
- biospace.com/
LLY
|
News
|
$731.33
0.69%
0.73%
12K
|
Health Technology
|
129.67%
|
O:
-0.47%
H:
1.04%
C:
0.64%
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
147.73%
|
O:
1.14%
H:
0.0%
C:
-3.37%
Cardiff Oncology Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
Published:
2023-03-02
(Crawled : 22:00)
- biospace.com/
LLY
|
News
|
$731.33
0.69%
0.73%
12K
|
Health Technology
|
132.78%
|
O:
-0.76%
H:
1.45%
C:
1.05%
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
153.49%
|
O:
0.58%
H:
1.16%
C:
0.0%
year
update
results
Cardiff Oncology to Present at the Cowen 43rd Annual Health Care Conference
Published:
2023-02-27
(Crawled : 14:00)
- biospace.com/
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
165.85%
|
O:
1.22%
H:
2.41%
C:
-1.2%
care
conference
health
Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer
Published:
2023-02-02
(Crawled : 14:20)
- biospace.com/
CRDF
|
$4.36
0.23%
-0.23%
1.1K
|
Health Services
|
154.97%
|
O:
0.58%
H:
3.49%
C:
1.74%
medical
← Previous
1
2
3
4
Next →
Gainers vs Losers
73%
27%
Top 10 Gainers
AGBA
|
$2.5
100.0%
58.33%
200M
|
Finance
EDBL
|
News
|
$6.26
66.49%
48.56%
270K
|
MLEC
|
$2.47
76.43%
38.05%
460K
|
n/a
SILO
|
$1.99
0.71%
20.64%
1.8M
|
Finance and Insurance
NNVC
|
$1.12
1.82%
19.64%
2.5K
|
Health Technology
CANG
|
$1.34
-4.29%
14.93%
120K
|
Technology Services
AZTR
4
|
$0.195
13.85%
42K
|
n/a
TOVX
|
News
|
$0.411
-1.01%
12.9%
230K
|
Manufacturing
IBRX
|
$4.94
-6.26%
10.83%
4.5M
|
Manufacturing
MSTR
M
|
$1324.01
12.77%
10.65%
26K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.